News

Sabra Healthcare (SBRA) reported $166.75 million in revenue for the quarter ended March 2024, representing a year-over-year increase of 3.4%. EPS of $0.35 for the same period compares to -$0.04 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $163.67 million, representing a surprise of +1.88%. The company delivered an EPS surprise of +2.94%, with the consensus EPS estimate being $0.34.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Sabra performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Interest and other income: $8.94 million versus the four-analyst average estimate of $8.95 million. The reported number represents a year-over-year change of +2.4%.
• Revenues- Resident fees and services: $66.03 million versus the three-analyst average estimate of $62.48 million. The reported number represents a year-over-year change of +16.4%.
• Revenues- Rental and related revenues: $91.78 million versus the three-analyst average estimate of $94.43 million. The reported number represents a year-over-year change of -4.3%.
• Net Earnings Per Share (Diluted): $0.11 versus $0.14 estimated by four analysts on average.

View all Key Company Metrics for Sabra here>>>

Shares of Sabra have returned +3% over the past month versus the Zacks S&P 500 composite's -0.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Top 5 Dividend Stocks for Your Retirement

Zacks targets 5 well-established companies with solid fundamentals and a history of raising dividends. More importantly, they have the resources and will to likely pay them in the future.

Click now for a Special Report packed with unconventional wisdom and insights you simply won’t get from your neighborhood financial planner.

See our Top 5 now – the report is FREE >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.